AR023975A1 - Nuevo gen lawsonia spp. y sus usos v - Google Patents
Nuevo gen lawsonia spp. y sus usos vInfo
- Publication number
- AR023975A1 AR023975A1 ARP000102294A ARP000102294A AR023975A1 AR 023975 A1 AR023975 A1 AR 023975A1 AR P000102294 A ARP000102294 A AR P000102294A AR P000102294 A ARP000102294 A AR P000102294A AR 023975 A1 AR023975 A1 AR 023975A1
- Authority
- AR
- Argentina
- Prior art keywords
- lawsonia
- lawsonia intracellularis
- prophylaxis
- treatment
- disease conditions
- Prior art date
Links
- 241001469654 Lawsonia <weevil> Species 0.000 title abstract 2
- 241001148567 Lawsonia intracellularis Species 0.000 abstract 3
- 241001465754 Metazoa Species 0.000 abstract 2
- 208000028774 intestinal disease Diseases 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 244000005700 microbiome Species 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 238000011321 prophylaxis Methods 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 238000011282 treatment Methods 0.000 abstract 2
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 229940039227 diagnostic agent Drugs 0.000 abstract 1
- 239000000032 diagnostic agent Substances 0.000 abstract 1
- 230000004727 humoral immunity Effects 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 244000052769 pathogen Species 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
La presente se refiere en general a composiciones terapéuticas para el tratamiento y/o profilaxis de condiciones de enfermedad intestinal en animales ypájaros causadas o exacerbadas por Lawsonia intracellularis o similar, u otros microorganismos relacionados. En particular, suministra un gen nuevo derivado deLawsonia inracellularis que codifica un péptido, polipéptido o proteína SodC inmunogénico que es particularmente util como antígeno en una preparacion paravacuna para conferir inmunidad humoral contra Lawsonia intracellularis y patogenos relacionados en huéspedes animales. La presente también está orientada amétodos para el tratamiento y/o profilaxis de dichas condiciones de enfermedad intestinal y a agentes de diagnostico y procedimientos para detectar LawsoniaIntracellularis o similar, u otros microorganismos relacionados.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13398999P | 1999-05-13 | 1999-05-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR023975A1 true AR023975A1 (es) | 2002-09-04 |
Family
ID=22461256
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP000102294A AR023975A1 (es) | 1999-05-13 | 2000-05-12 | Nuevo gen lawsonia spp. y sus usos v |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1177212A4 (es) |
| JP (1) | JP2003501013A (es) |
| AR (1) | AR023975A1 (es) |
| AU (1) | AU4385800A (es) |
| BR (1) | BR0011292A (es) |
| CA (1) | CA2372095A1 (es) |
| MX (1) | MXPA01011670A (es) |
| NZ (1) | NZ515332A (es) |
| PE (1) | PE20010238A1 (es) |
| WO (1) | WO2000069903A1 (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6605696B1 (en) | 1999-10-22 | 2003-08-12 | Pfizer, Inc. | Lawsonia intracellularis proteins, and related methods and materials |
| DK1219711T3 (da) | 2000-12-20 | 2006-09-25 | Intervet Int Bv | Lawsonia Intracellularis vaccine |
| US7662390B2 (en) | 2003-09-12 | 2010-02-16 | Intarvet International B.V. | Lawsonia intracellularis subunit vaccine |
| MXPA06008217A (es) | 2004-01-22 | 2007-05-23 | Intervet Int Bv | Vacunas con subunidad de lawsonia intracellularis. |
| US8834891B2 (en) | 2005-03-14 | 2014-09-16 | Boehringer Ingelheim Vetmedica, Inc. | Immunogenic compositions comprising Lawsonia intracellularis |
| US8398994B2 (en) | 2005-07-15 | 2013-03-19 | Boehringer Ingelheim Vetmedica, Inc. | Lawsonia vaccine and methods of use thereof |
| EP2859900A1 (en) | 2006-12-11 | 2015-04-15 | Boehringer Ingelheim Vetmedica, Inc. | Effective method of treatment of porcine circovirus and lawsonia intracellularis infections |
| CN111830257B (zh) * | 2020-07-17 | 2023-10-24 | 南京农业大学 | 一种猪源胞内劳森菌ipma抗原检测方法及其应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5885823A (en) * | 1995-06-05 | 1999-03-23 | Nobl Laboratories, Inc. | Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents |
| US7022328B1 (en) * | 1995-11-30 | 2006-04-04 | Australian Pork Limited | Therapeutic and diagnostic compositions |
-
2000
- 2000-05-11 JP JP2000618319A patent/JP2003501013A/ja active Pending
- 2000-05-11 NZ NZ515332A patent/NZ515332A/xx unknown
- 2000-05-11 BR BR0011292-5A patent/BR0011292A/pt not_active IP Right Cessation
- 2000-05-11 CA CA002372095A patent/CA2372095A1/en not_active Abandoned
- 2000-05-11 WO PCT/AU2000/000436 patent/WO2000069903A1/en not_active Application Discontinuation
- 2000-05-11 EP EP00924975A patent/EP1177212A4/en not_active Withdrawn
- 2000-05-11 MX MXPA01011670A patent/MXPA01011670A/es unknown
- 2000-05-11 AU AU43858/00A patent/AU4385800A/en not_active Abandoned
- 2000-05-12 PE PE2000000445A patent/PE20010238A1/es not_active Application Discontinuation
- 2000-05-12 AR ARP000102294A patent/AR023975A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000069903A1 (en) | 2000-11-23 |
| BR0011292A (pt) | 2002-02-26 |
| EP1177212A4 (en) | 2002-08-28 |
| CA2372095A1 (en) | 2000-11-23 |
| PE20010238A1 (es) | 2001-03-03 |
| JP2003501013A (ja) | 2003-01-14 |
| MXPA01011670A (es) | 2003-10-14 |
| EP1177212A1 (en) | 2002-02-06 |
| AU4385800A (en) | 2000-12-05 |
| NZ515332A (en) | 2004-01-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2325737T3 (es) | Vacuna para enfermedad periodontal. | |
| ES2583484T3 (es) | Vacuna de toxoide alfa de C. perfringens | |
| UA87665C2 (ru) | Авирулентный изолят lawsonia intracellularis европейского происхождения, вакцина для иммунизации животных, применение заявленного авирулентного изолята как вакцины, способ получения вакцины, способ культивирования lawsonia intracellularis, способ диагностики пролиферативной энтеропатии свиней и способ получения антисыворотки к lawsonia intracellularis | |
| Droppa-Almeida et al. | Recombinant CP40 from Corynebacterium pseudotuberculosis confers protection in mice after challenge with a virulent strain | |
| BR9909483A (pt) | Derivados de proteìnas ligantes pneumococcal colina para vacinas | |
| BRPI0410795A (pt) | composições para tratamento de infecção em bovinos e suìnos | |
| BR0211049A (pt) | Método de tratamento ou prevenção de doenças ou disfunções e uso de mycoplasma hyopneumoniae | |
| TW200800255A (en) | Vaccines for immunization against Helicobacter | |
| AR023975A1 (es) | Nuevo gen lawsonia spp. y sus usos v | |
| BR0309570A (pt) | Fatores camp quiméricos para vacinação contra infecção por streptococcus | |
| MX2012003827A (es) | Toxina rtx citolitica de gallibacterium anatis. | |
| BRPI0419273A (pt) | composições e métodos para tratar infecções microbianas e parasìticas em gado vacum e outros animais | |
| Spithill et al. | Prospects for immunoprophylaxis against Fasciola hepatica (liver fluke) | |
| BR112021020777A2 (pt) | Vacina de subunidade do csfv | |
| PH12020552130A1 (en) | Vaccination against porcine circoviruses | |
| NZ515330A (en) | Lawsonia derived gene and related OmpH polypeptides, peptides and proteins and their uses | |
| WO2005056601A3 (en) | Human anti-pseudomonas-aeruginosa antibodies derived from transgenic xenomouse? | |
| BR0011294A (pt) | Gene derivado lawsonia e polipeptìdeos, peptìdeos e proteìnas flge relacionados e seus usos | |
| JP2011103893A (ja) | 組換えインフルエンザ菌アドヘシンタンパク質 | |
| BR0114835A (pt) | Composições terapêuticas para tratamento de infecção por lawsonia spp | |
| Vicente et al. | A Fasciola hepatica-derived fatty acid binding protein induces protection against schistosomiasis caused by Schistosoma bovis using the adjuvant adaptation (ADAD) vaccination system | |
| BR112022020438A2 (pt) | Composições compreendendo três proteínas de fusão ospa para uso médico | |
| CA2929126C (en) | Outer membrane vesicles and uses thereof | |
| BRPI0414073A (pt) | método para induzir uma resposta imune contra infecção por rotavìrus a partir de um sorotipo de rotavìrus, e, uso de uma cepa de rotavìrus atenuado de um sorotipo | |
| EP2200641B1 (en) | Compositions for eliciting an immune response against mycobacterium avium subspecies paratuberculosis |